NMITLI Program for Multi Institutional Project to Develop Human Monoclonal Antibodies (hmAbs)
CSIR is leading the fight against Covid-19 using multi-pronged approach and multiple models of engagement. On one hand CSIR labs themselves are developing technologies and products and are working with industry and PSU partners for deployment. On the other hand, CSIR is also supporting new ideas and projects from other academic and industries through its flagship New Millennium Indian Technology Leadership Initiative (NMITLI) program.